Drug · DIN 02377438
HALAVEN
2 ML SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 19, 2012; first marketed March 19, 2012.
- Drug Identification Number (DIN)
- 02377438
- Company (DIN owner)
- Eisai LimitedWoodcliff Lake, New Jersey, United States
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Eribulin L01XX41
- Class
- Human
- Record last updated
- August 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ERIBULIN MESYLATE | 0.5 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 14, 2011: NOC 12871New Drug Submission (NDS)